Physician

Kenneth S Schor, M.D.

According to 2025 Medicare claims, Kenneth Schor, M.D. (NPI: 1407009228) practices ophthalmology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is EYE DOCTORS OF WASHINGTON PC (NPI: 1952438202; TIN: 521759220) and primary practice location at 20814-3014.

Schor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 995 traditional Medicare patients, billed 4,412 HCPCS/CPT codes, and received $431,377 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,278 prescription claims across 446 beneficiaries totaling $373,259 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 56 records totaling $3,024. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $248,703 to $431,377. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $153,963 to $373,259. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$247K$494K2015 Medicare payment: $248,703 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $223,472 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $227,341 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $269,271 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $352,983 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $299,487 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $447,842 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $493,873 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $437,652 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $431,377 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156953,381$248,703
20166013,012$223,472
20176133,236$227,341
20187063,735$269,271
20198254,382$352,983
20207703,873$299,487
20219284,986$447,842
20221,0665,102$493,873
20231,0564,775$437,652
20249954,412$431,377

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$187K$373K2015 Drug cost: $153,963 (USD; Tot_Drug_Cst)2016 Drug cost: $199,337 (USD; Tot_Drug_Cst)2017 Drug cost: $221,461 (USD; Tot_Drug_Cst)2018 Drug cost: $275,787 (USD; Tot_Drug_Cst)2019 Drug cost: $350,454 (USD; Tot_Drug_Cst)2020 Drug cost: $351,600 (USD; Tot_Drug_Cst)2021 Drug cost: $360,953 (USD; Tot_Drug_Cst)2022 Drug cost: $352,797 (USD; Tot_Drug_Cst)2023 Drug cost: $349,691 (USD; Tot_Drug_Cst)2024 Drug cost: $373,259 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152881,229$153,963
20162891,476$199,337
20172351,274$221,461
20182531,291$275,787
20192941,576$350,454
20202941,627$351,600
20213241,700$360,953
20223491,822$352,797
20234041,965$349,691
20244462,278$373,259

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system693906$103
92012Established patient problem focused exam of visual system329424$74
92083Exam of visual field with extended testing435478$51
92250Photography of the retina385398$29
92133Imaging of optic nerve471507$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost1187,617$65,407
RestasisCyclosporine322,040$41,494
CombiganBrimonidine Tartrate/Timolol593,595$28,175
RhopressaNetarsudil Mesylate492,411$26,511
VyzultaLatanoprostene Bunod552,610$23,501

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.56$3,024Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kenneth S. Schor, M.D.?

Tedicare shows public-source Medicare data for Kenneth S. Schor, M.D. (NPI 1407009228), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kenneth S. Schor, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kenneth S. Schor, M.D.?

Kenneth S. Schor, M.D. is linked to EYE DOCTORS OF WASHINGTON PC (billing NPI 1952438202) in the available physician profile data.

Does Kenneth S. Schor, M.D. have Open Payments data?

Kenneth S. Schor, M.D. has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.